News

Pfizer withdraws Oxbryta from global markets, cites safety concerns

Pfizer has voluntarily withdrawn Oxbryta (voxelotor), a conditionally approved oral therapy for sickle cell disease (SCD), from worldwide markets, saying clinical data shows the treatment’s benefit “no longer outweighs the risk.” Citing an imbalance in vaso-occlusive crises (VOCs) and deaths occurring in patients given Oxbryta in postmarketing…

NewYork-Presbyterian awareness campaign has basketball theme

The NewYork-Presbyterian Dalio Center for Health Justice is using basketball to raise awareness about sickle cell disease (SCD). The Sickle Cell Awareness Ball campaign features a special-edition basketball with one crescent-shaped red panel, representing the cell that’s a hallmark feature of the disease. The black-and-red ball is featured…

‘Sickle Cell Matters’ during Sickle Cell Awareness Month

The sickle cell disease (SCD) community will mark National Sickle Cell Awareness Month through September to help bring greater visibility to the inherited blood disorder and the roughly 100,000 U.S. residents affected by it. The campaign also seeks to raise funds for research and support those with SCD and…